Scar Treatment Market Size, Share and Trends 2026 to 2035

Scar Treatment Market (By Treatment Type: Topical, Laser, Surface, Surgical, Injectable; By Scar Type: Acne & Atrophic, Stretch Marks, Hypertrophic & Keloid, Contracture; By End Use: Dermatology Clinics, Home-Use, Hospitals) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 27 Mar 2026  |  Report Code : 1303  |  Category : Healthcare   |  Format : PDF / PPT / Excel   |  Author : Deepa Pandey   | Reviewed By : Aditi Shivarkar
Revenue, 2025
USD 32.29 Bn
Forecast Year, 2035
USD 81.98 Bn
CAGR, 2026 - 2035
9.77%
Report Coverage
Global

What is the Scar Treatment Market Size?

The global scar treatment market size is valued at USD 32.29 billion in 2025 and is predicted to increase from USD 35.65 billion in 2026 to approximately USD 81.98 billion by 2035, expanding at a CAGR of 9.77% from 2026 to 2035.

Scar Treatment Market Size 2026 to 2035

Scar Treatment Market Key Takeaways

  • In terms of revenue, the market is valued at $32.29 billion in 2025.
  • It is projected to reach $81.98billion by 2035.
  • The market is expected to grow at a CAGR of 9.77% from 2026 to 2035.
  • North America led the global market with the highest market share of 38% in 2025.
  • Asia-Pacific is expected to expand at the largest CAGR of 12% between 2026 and 2035.
  • By Treatment Type, the topical segment has held the highest market share of 60.5% in 2025.
  • By Treatment Type, the laser segment is anticipated to grow at a fastest CAGR from 2026 to 2035.
  • By Scar Type, the acne & atrophic segment had the major market share in 2025.
  • By Scar Type, the hypertrophic & keloid segment is projected to expand at the fastest CAGR over the projected period.
  • By End Use, the home-use segment generated more than 45% of revenue share in 2025.
  • By End Use, the hospitals segment is estimated to grow at the fastest CAGR over the projected period.

What is the Scar Treatment?

The scar treatment industry contains products and treatments that lessen the size of scars and enhance the skin. It addresses both the topical solutions, laser treatments, and injections in the home care and clinic settings. The increase is motivated by the increased number of injuries, surgeries, and beauty consciousness. Topical products are leading by virtue of their availability. State-of-the-art laser technologies are becoming common. The market is moving towards early and aggressive scar management using a combined professional and home care strategy.

How is AI contributing to the Scar Treatment Industry?

AI has revolutionized the treatment of scars with accurate evaluation and individualized treatment. The features of the scar are highly evaluated using computer vision. Machine learning forecasts healing trends and provides appropriate treatment. The lasers are controlled by AI to achieve enhanced results by modulating intensity as it goes. Follow-ups are enhanced by remote monitoring using smart devices.

The use of advanced tools is also used to simulate the results of post-treatment and assist patients in making informed decisions, and the whole treatment experience can be greatly improved.

Scar Treatment Market Growth Factors

The growing concerns among the population regarding their aesthetic appearances are a major factor driving the growth of the global scar treatment market. Scars due to accidents and other reasons is propelling the demand for the scar treatment products and services. The growing demand among women for improving aesthetic appeal and skin rejuvenation is significantly driving the market growth. Moreover, rising prevalence of skin diseases and increasing awareness regarding scar treatment among the population is fueling the market growth globally. The excessive exposure to sunlight and pollution may cause skin disease such as photo-aging, psoriasis, sunburns, and vitiligo. These diseases may lead to scars if not treated properly. Other scars such as burns, acne, stretch marks, and surgical scars are the various factors that are exponentially contributing towards the skin treatment market growth globally.

The growth in the number of road accidents across the globe is another driving factor for the scar treatment market. According to a data published by the Population Reference Bureau, every year, around 50 million individuals are injured due to road accidents. According to the World Health Organization, around 1.3 million people die in road accidents every year. Moreover, the children and the young adults are the major victims of road accidents. Hence, these two age groups are one of the consumers of scar treatment products. Hence, the rising number of road accident cases is fueling the growth of the global scar treatment market.

Market Outlook

  • Industry Growth Overview: The scar treatment market is growing, driven by rising aesthetic challenges, an increasing incidence of skin trauma due to accidents, burns, surgeries, acne, and incessant technological development in treatment choices. Also, increasing demand for efficient scar management services.
  • Global Expansion: The scar treatment industry is expanding globally due to increasing societal emphasis on physical appearance and self-confidence. North America is a dominant market due to its developed medical care infrastructure and massive consumer spending on cosmetics. The Asia-Pacific region is the fastest-growing market, as increasing disposable incomes and urbanization in this region.
  • Major investors:Major investors are large healthcare and pharmaceutical organizations, as well as dedicated venture capital and private equity firms that heavily invest in health tech and life sciences. It includes Smith & Nephew plc, Perrigo Company plc, Bausch Health Companies Inc., and others.

Market Scope

Report Coverage Details
Market Size by 2035 USD 81.98 Billion
Market Size in 2025 USD 32.29 Billion
Market Size in 2026 USD 35.65 Billion
Growth Rate from 2026 to 2035 CAGR of 9.77%
Base Year 2025
Forecast Period 2026 to 2035
Largest Market North America
Segments Covered Treatment Type, Scar Type, End Use, Region
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Segment Analysis

Treatment Type Analysis

The topical segment led the largest revenue share 60.5% in 2024 and is anticipated to retain its dominance throughout the forecast period. This is attributed to the growing demand and easy availability of the topical products such as silicone sheets, gels, oils, ointments, sprays, and creams. These products are directly applied on the skin by the consumers to treat scars. These are easily available over the counter products. Moreover, the rising penetration of retail pharmacies and online pharmacies are expected to fuel the growth of the segment.

On the other hand, the laser is estimated to be the most opportunistic segment during the forecast period. Laser scar treatment is the latest and advanced technology for scar treatment. Moreover, laser treatment of scars is painless and non-invasive and it provides instant results without any discomfort. Hence, this is expected to be the fastest-growing segment in the forthcoming years.

Scar TypeAnalysis

The acne & atrophic segment led the global scar treatment market with remarkable revenue share in 2024 and is anticipated to retain its dominance throughout the forecast period. Acne & atrophic scars occurs due to the insufficiency of skin to produce adequate collagen to heal the scare or injury. These types of scars are generally treated with lotions, oils, gels, and creams that are easily available as OTC products.

On the other hand, the hypertrophic & keloid is anticipated to be the most opportunistic segment during the forecast period. This is attributed to the rising number of traumatic wounds, surgical procedures, and burn injuries. Moreover, growing cases of road accidents is fueling the growth of this segment.

End UseAnalysis

The home-use segment accounted the market with revenue share of 45% in 2024 and is anticipated to retain its dominance throughout the forecast period. This is attributable to the growing consumption of topical products such as silicone sheets, creams, and lotions by the consumers to treat scars.

On the other hand, the hospitals are expected to be the fastest-growing segment during the forecast period, due to the availability of advanced technologies and cosmopolitan infrastructure for scar treatment.

Regional Insights

U.S. Scar Treatment Market Size and Growth 2026 to 2035

The U.S. scar treatment market size is valued at USD 8.61 billion in 2025 and is estimated to reach around USD 22 billion by 2035, growing at a CAGR of 9.84% from 2026 to 2035.

U.S. Scar Treatment Market Size 2026 to 2035

The North America accounted the market with 38% revenue share in 2025 and is estimated to sustain its dominance during the forecast period. This is attributable to the higher awareness among the population regarding their aesthetic appearance, easy availability of scar treatment products, increased personal disposable income, developed infrastructure in hospitals, and higher adoption of technologically advanced equipment. Moreover, rising cases of burn injuries is fostering the market in North America. As per the American Burn Association, there are more than 485,000 burn injury cases reported in US every year. Further, the presence of some of the key market players in US such as CCA Industries, Scar Heal, Inc., and Sonoma Pharmaceuticals are contributing significantly in the growth of the scar treatment market in this region.

  • In April 2025, Candela Corporation, a global leader in energy-based medical aesthetics, proudly announced the launch of the Vbeam Pro platform at the 2025 Annual Meeting of the American Society for Laser Medicine and Surgery (ASLMS). The Vbeam Pro device is the only vascular laser FDA-cleared for use in pediatric patients and combines an advanced 595 nm pulsed dye laser with a 1064 nm Nd: YAG wavelength to provide unmatched exactness, accuracy, and treatment versatility.Source: Candela Medical

U.S. Scar Treatment Market Trends

The US leads the global in pharmaceutical R&D spending, with both private and public institutions. The US has a strong culture of revolution and entrepreneurship, which fascinates top technical talent worldwide and encourages partnership in the academic institutions, biotech firms, and regulatory agencies. Increasing FDA approval drives the growth of the market.

  • In April 2025, AVAVA, a medical aesthetics innovation company redefining energy-based skin therapy, announced today that its advanced acne scar treatment using Focal Point Technology has received clearance from the U.S. Food and Drug Administration (FDA). Source: Globe NewsWire
Scar Treatment Market Share By Region 2025(%)

Asia Pacific region is estimated the highest CAGR of 12% during the forecast period. This is majorly due to the growing infrastructural investments by the government and private players in the healthcare and pharmaceutical industry, growing number of road accident cases, and rising awareness among the population regarding aesthetic appearances. According to the WHO, around 93% of the global road accidents occur in underdeveloped and developing countries. Moreover, developing nation like India is a leading contributor to the global road accident cases. Hence, the growing number of road accidents is a major contributing factor to the growth of the scar treatment market in the region.

  • In October 2025, 4D Molecular Therapeutics announced a strategic partnership with Otsuka Pharmaceutical Co., Ltd. (Otsuka) to develop and commercialize 4D-150 for the treatment of wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) in the greater Asia-Pacific (APAC) region, including Japan. Source: Globe NewsWire

India Scar Treatment Market Trends

India has a large pool of advanced-trained, skillful physicians and surgeons, many of whom have received training and experience from prestigious international organizations. The majority of Indian hospitals are equipped with advanced technology and modern infrastructure, adhering to international ethics, which drives the growth of the market.

Europe is Significantly Growing in the Scar Treatment Market

Europe is significantly growing in the scar treatment market, driven by increasing preference for non-invasive methods, such as lasers and advanced topical applications, which provide reduced downtime and challenges compared to surgical treatment. The growing adoption of ASCs offers more accessible and affordable treatment choices for patients. Presence of major companies in the European scar management market includes Advancis Medical, Bayer AG, B. Braun SE, Molnlycke Health Care AB, Smith & Nephew, and Stratpharma AG.

  • In October 2025, the European Innovation Council (EIC), part of the EU research and innovation programme Horizon Europe, will support European deep tech research and high-potential start-ups with €1.4 billion next year. The EIC Work Programme 2025, which the Commission adopted today, represents an increase of nearly €200 million in comparison with 2024. Source: European Commission

The UK Scar Treatment Market Trends

In the UK, increasing customer awareness of aesthetic appearance, a growing prevalence of situations that cause scars, like acne, and an increasing rate of obesity, which drives demand for advanced treatment options. Advancement in laser therapies, microneedling, and advanced topical products contributes to the growth of the market.

Scar Treatment Market - Value Chain Analysis

  • R&D: R&D process in scar treatment involves the development and testing of advanced laser techniques, novel topical and injectable products, targeted medicine technology, and dedicated formulations for precise scar types.
    Key Players: AbbVie and Innovo Therapeutics
  • Clinical Trials:Clinical trials on scar treatment are vigorously investigating different processes, including laser systems like the MIRIA laser for acne scars and non-ablative lasers for scarring alopecia.
    Key Players: Kringle Pharma and CellinCells
  • Patient Services: Patient services involve a wide range of treatments from topical applications and laser therapy to surgical revision and physiotherapy. Key services are topical treatments, laser therapy, surgical revision, injection-based treatments, physiotherapy, and other methods
    Key Players: CUTISS AG and BirchBioMed.

Key Players in Scar Treatment Market & Their Offerings

Company Headquarters Key Strengths Latest Info (2025)

Bausch Health Companies, Inc .

Canada Medical devices and OTC products In September 2025, Bausch Health's Aesthetic Business, Solta Medical, Surpasses Milestone of 5 Million Skin Tightening Treatments with Thermage Non-Surgical System
Candela Corp. Marlborough, Massachusetts Advanced technology, strong global presence In April 2025, Candela Corporation introduced the Vbeam Pro platform at the 2025 ASLMS event.
Sonoma Pharmaceuticals, Inc. Boulder, Colorado Proprietary Microcyn Technology In April 2025, Sonoma received regulatory approval for the sale of its wound care products in Ukraine as a Class IIb medical device.
Hologic, Inc. United States focused expertise in women's health Hologic previously owned Cynosure, a division that provides light-based aesthetic treatments, including applications for scar reduction.
Quantum, Inc. San Jose, California Specialization in Unstructured Data Quantum Health provides an intensive herbal and nutrient cream intended to soften and lower the appearance of new and present scars.

Other Major Key Players

  • Johnson & Johnson
  • CCA Industries, Inc.
  • Avita Medical Ltd.
  • Revitol Corp.
  • Scarguard Labs, LLC.

Recent Developments

  • In January 2026, BIOCORNEUM launches SiliSilk, a non-SPF silicone gel for scar recovery, developed by experts in silicone management. This clinically proven option is suitable for indoor use or beneath clothing, offering professional-grade silicone in a comfortable, non-greasy gel format for enhanced scar treatment.
    (Source: https://www.prnewswire.com )
  • In May 2025, Kaya, India's leading dermatology clinic chain, exclusively offers Aerolase, a revolutionary laser treatment for active acne and scars, available only at Kaya clinics for one year. This launch highlights Kaya's commitment to safe, effective, non-invasive dermatological solutions.
    (Source: https://www.business-standard.com )
  • In March 2024, Scar Erase has just launched a silicone scar therapy strip that is meant to aid the LGBTQ+ community in managing scars, no matter through their gender-affirming surgeries or injuries, or acne. Scar Erase's product is making a significant impact.
    (Source: https://mygwork.com )
  • In January 2023, Sonoma Pharmaceuticals, Inc. launched an offering of office products for skin care professionals to use in their practice.
    (Source: https://www.fda.gov )
  • In March 2024, the U.S. FDA approved Rezdiffra (resmetirom) for adults with NASH (non-cirrhotic non-alcoholic steatohepatitis) with moderate to advanced liver scarring.
    (Source: https://www.jwatch.org )

Segments Covered in the Report

By Treatment Type

  • Topical
  • Laser
  • Surface
  • Surgical
  • Injectable

By Scar Type

  • Acne & Atrophic
  • Stretch Marks
  • Hypertrophic & Keloid
  • Contracture

By End Use

  • Dermatology Clinics
  • Home-Use
  • Hospitals

By Geography

  • North America
  • Latin America
  • Europe
  • Asia-pacific
  • Middle and East Africa

For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : According to Precedence Research, the global scar treatment market is valued at USD 32.29 billion in 2025 and is projected to reach USD 81.98 billion by 2035.

Answer : The global scar treatment market is growing at a compound annual growth rate (CAGR) of 9.77% from 2026 to 2035.

Answer : The major players operating in the scar treatment market are Bausch Health Companies, Inc., Candela Corp., Sonoma Pharmaceuticals, Inc., Hologic, Inc., Johnson & Johnson, Quantum, Inc., CCA Industries, Inc., Avita Medical Ltd., Revitol Corp., Scarguard Labs, LLC.

Answer : Rising prevalence of skin diseases, growing concerns among the young population regarding their looks and growing number of road accidents are the driving factors of the scar treatment market.

Answer : The North America lead the market with 38% revenue share in 2025.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

Meet the Team

Deepa Pandey

Deepa Pandey

Author

Deepa Pandey is the principal consultant in the precedence research, with 2+ years of experience in the market research industry.With a Master’s in Pharmacy specializing in Pharmaceutical Quality Assurance, Deepa Pandey brings a unique combination of scientific knowledge and market research expertise to Precedence Research. She plays a critical role in shaping the content and analysis that define the firm’s research reports. Over the past five years, Deepa has contributed to over 70 reports, providing clients with clear, actionable insights into the healthcare and pharmaceutical industries. Her deep understanding of regulatory requirements, quality processes, and operational dynamics allows her to translate complex information into practical strategies for global stakeholders.

Read more about Deepa Pandey
Aditi Shivarkar

Aditi Shivarkar

Reviewed By

Aditi brings more than 14 years of experience to Precedence Research, serving as the driving force behind the accuracy, clarity, and relevance of all research content. She reviews every piece of data and insight to ensure it meets the highest quality standards, supporting clients in making informed decisions. Her expertise spans healthcare, ICT, automotive, and diverse cross-industry domains, allowing her to provide nuanced perspectives on complex market trends. Aditi’s commitment to precision and analytical rigor makes her an indispensable leader in the research process.

Learn more about Aditi Shivarkar

Related Reports